Structures by: Johannes H. H.
Total: 15
C19H16N2
C19H16N2
Organic letters (2012) 14, 19 5090-5093
a=8.3778(4)Å b=11.2485(6)Å c=15.3805(8)Å
α=90.00° β=103.626(3)° γ=90.00°
C18H15N2O0.5
C18H15N2O0.5
Organic letters (2012) 14, 19 5090-5093
a=23.4787(18)Å b=6.9212(6)Å c=16.9815(12)Å
α=90.00° β=107.401(3)° γ=90.00°
C50H49IrN6O2
C50H49IrN6O2
Chemical communications (Cambridge, England) (2017) 53, 23 3295-3298
a=13.0020(3)Å b=18.8143(3)Å c=17.6588(4)Å
α=90.00° β=110.919(2)° γ=90.00°
C64H53IrN3O
C64H53IrN3O
Chemical communications (Cambridge, England) (2017) 53, 23 3295-3298
a=20.9475(4)Å b=12.09289(17)Å c=20.1184(4)Å
α=90.00° β=106.360(2)° γ=90.00°
C62.67H50.33IrN6O0.67
C62.67H50.33IrN6O0.67
Chemical communications (Cambridge, England) (2017) 53, 23 3295-3298
a=13.7534(4)Å b=19.6098(6)Å c=27.0140(5)Å
α=95.925(2)° β=93.542(2)° γ=94.992(3)°
C26H19Cl4IrN2O3
C26H19Cl4IrN2O3
Dalton Transactions (2008) 31 4095-4098
a=11.4605(11)Å b=14.1259(14)Å c=16.6417(16)Å
α=89.693(2)° β=83.124(2)° γ=85.740(2)°
10-Iodo-bis(5-iodo-1,3,3-trimethylindoline-2yl)monomethinium Perchlorate
C23H24I3N21,ClO41
Acta Crystallographica Section C (1997) 53, 10 1432-1434
a=11.448(2)Å b=12.098(2)Å c=19.305(3)Å
α=90.00° β=106.30(2)° γ=90.00°
C39H39N21,C6H2N3O71
C39H39N21,C6H2N3O71
Acta Crystallographica Section C (1997) 53, 9 1363-1366
a=11.697(6)Å b=12.788(7)Å c=14.138(7)Å
α=99.72(4)° β=100.14(4)° γ=109.04(3)°
Mer-Bis[2-(6-fluoro-3-methylquinoxalin-2-yl-κN^1^)phenyl][3-phenyl-5- (2-pyridyl-κN)-1,2,4-triazol-1-yl]iridium(III) dichloromethane disolvate
C43H29F2IrN8,2CH2Cl2
Acta Crystallographica Section E (2006) 62, 9 m2202-m2204
a=19.1184(14)Å b=12.5390(8)Å c=18.2869(12)Å
α=90.00° β=110.521(4)° γ=90.00°
Rac-(2R,3S)-2-Phenyl-3-(3-phenyl-1,2,3,4-tetrahydroquinoxalin-2-yl)quinoxaline
C28H22N4
Acta Crystallographica Section E (2008) 64, 7 o1205-o1206
a=11.1601(6)Å b=11.3987(6)Å c=16.4638(8)Å
α=90.00° β=93.170(2)° γ=90.00°
<i>mer</i>-Bis[2-(1,3-benzothiazol-2-yl)phenyl-κ^2^<i>C</i>^1^,<i>N</i>]{3- phenyl-5-(2-pyridyl)-1,2,4-triazol-1-ido- κ^2^<i>N</i>^1^,<i>N</i>^5^}iridium(III) deuterochloroform 3.5-solvate
C39H25IrN6S2,3.5(CDCl3)
Acta Crystallographica Section E (2010) 66, 9 m1088-m1089
a=11.7521(4)Å b=13.5592(4)Å c=15.8373(4)Å
α=74.045(3)° β=79.247(3)° γ=76.002(3)°
<i>mer</i>-[3-Phenyl-5-(2-pyridyl-κ<i>N</i>)-1,2,4-triazol-1-ido- κ<i>N</i>^1^]bis(2-quinolylphenyl-κ^2^<i>C</i>^1^,<i>N</i>)iridium(III) deuterochloroform disolvate
C43H29IrN6,2(CDCl3)
Acta Crystallographica Section E (2010) 66, 11 m1408-m1409
a=9.1399(3)Å b=12.4430(5)Å c=17.6762(6)Å
α=81.493(4)° β=81.509(4)° γ=85.193(4)°
8-(Biphenyl-2-yl)-7,9-diphenyl-8<i>H</i>-cyclopenta[<i>a</i>]acenaphthylen-8-ol
C39H26O
Acta Crystallographica Section E (2009) 65, 4 o927
a=7.3837(4)Å b=18.4001(12)Å c=19.2505(12)Å
α=90.00° β=97.549(3)° γ=90.00°
<i>mer</i>-Bis[3,5-difluoro-2-(2-pyridyl)phenyl-κ^2^<i>C</i>^1^,<i>N</i>]{5- (2-pyridyl-κ<i>N</i>)-3-[3-(4-vinylbenzyloxy)phenyl]-1,2,4-triazol-1- ido}iridium(III) methanol solvate
C44H29F4IrN6O,CH4O
Acta Crystallographica Section E (2010) 66, 1 m66-m67
a=9.89340(10)Å b=12.3039(2)Å c=16.8933(3)Å
α=81.7429(14)° β=83.2858(11)° γ=69.9647(14)°
C49H40Cl3F2IrN7
C49H40Cl3F2IrN7
Organometallics (2012) 31, 15 5223
a=9.5540(3)Å b=14.2139(5)Å c=17.0434(6)Å
α=98.609(3)° β=100.840(3)° γ=98.216(3)°